- Home
- KROS vs CYH Comparison
KROS vs CYH Comparison
Compare KROS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CYH
- Stock Information
- Founded
- KROS 2015
- CYH 1985
- Country
- KROS United States
- CYH United States
- Employees
- KROS 163
- CYH N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- KROS Health Care
- CYH Health Care
- Exchange
- KROS Nasdaq
- CYH Nasdaq
- Market Cap
- KROS 558.9M
- CYH 482.7M
- IPO Year
- KROS 2020
- CYH 1991
- Fundamental
- Price
- KROS $13.35
- CYH $3.33
- Analyst Decision
- KROS Buy
- CYH Hold
- Analyst Count
- KROS 13
- CYH 8
- Target Price
- KROS $20.63
- CYH $4.27
- AVG Volume (30 Days)
- KROS 620.1K
- CYH 2.4M
- Earning Date
- KROS 08-06-2025
- CYH 07-23-2025
- Dividend Yield
- KROS N/A
- CYH N/A
- EPS Growth
- KROS N/A
- CYH N/A
- EPS
- KROS 0.11
- CYH N/A
- Revenue
- KROS $214,713,000.00
- CYH $12,653,000,000.00
- Revenue This Year
- KROS $5,006.76
- CYH N/A
- Revenue Next Year
- KROS N/A
- CYH $3.49
- P/E Ratio
- KROS $123.16
- CYH N/A
- Revenue Growth
- KROS 91657.70
- CYH 1.05
- 52 Week Low
- KROS $9.12
- CYH $2.24
- 52 Week High
- KROS $72.37
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- KROS 43.06
- CYH 51.63
- Support Level
- KROS $13.41
- CYH $3.28
- Resistance Level
- KROS $13.99
- CYH $3.56
- Average True Range (ATR)
- KROS 0.44
- CYH 0.20
- MACD
- KROS -0.07
- CYH -0.02
- Stochastic Oscillator
- KROS 9.84
- CYH 50.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.